SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-24-004302
Filing Date
2024-02-09
Accepted
2024-02-09 19:56:57
Documents
1
Period of Report
2024-02-07

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3718
  Complete submission text file 0001127602-24-004302.txt   5440
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Issuer) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O AXCELLA HEALTH, INC. 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Viehbacher Christopher (Reporting) CIK: 0001774478 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19311 | Film No.: 24617026